Literature DB >> 21308011

Diagnosis and management of inflammatory bowel disease.

D J Buchan.   

Abstract

The onset of ulcerative colitis is characterized by diarrhea and bleeding, while granulomatous ileocolitis may be similar or more obscure with abdominal pain, bowel obstruction, loss of weight, iritis, arthritis or hypoalbuminemia. The diagnosis in ulcerative colitis is made by sigmoidoscopy and barium enema, while small bowel follow through is necessary in ileocolitis. Ulcerative colitis is treated by adrenocorticosteroids as retention enemas when limited to the left colon, intravenous ACTH or steroids in severe pancolitis and oral steroids in others. Sulphasalazine is used in addition to steroids in acute cases and as maintenance to prevent exacerbations. Proctocolectomy is indicated in those with severe disease with complications not responding to steroids. The treatment of Crohn's disease is similar but complicated by small bowel involvement and recurrence after surgery.

Entities:  

Year:  1976        PMID: 21308011      PMCID: PMC2378197     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  11 in total

1.  CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.

Authors:  A P DICK; M J GRAYSON; R G CARPENTER; A PETRIE
Journal:  Gut       Date:  1964-10       Impact factor: 23.059

2.  A CONTROLLED THERAPEUTIC TRIAL OF VARIOUS DIETS IN ULCERATIVE COLITIS.

Authors:  R WRIGHT; S C TRUELOVE
Journal:  Br Med J       Date:  1965-07-17

3.  Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis.

Authors:  S C TRUELOVE; G WATKINSON; G DRAPER
Journal:  Br Med J       Date:  1962-12-29

4.  A controlled evaluation of intravenous adrenocorticotropic hormone and hydrocortisone in the treatment of acute colitis.

Authors:  H P Kaplan; B Portnoy; H J Binder; T Amatruda; H Spiro
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

5.  Controlled trial of azathioprine in Crohn's disease.

Authors:  J M Willoughby; J Beckett; P J Kumar; A M Dawson
Journal:  Lancet       Date:  1971-10-30       Impact factor: 79.321

6.  Azathioprine for Crohn's disease.

Authors:  B N Brooke; D C Hoffmann; E T Swarbrick
Journal:  Lancet       Date:  1969-09-20       Impact factor: 79.321

7.  Controversy on recurrent ileitis after ileostomy: background and speculation.

Authors:  B I Korelitz; H D Janowitz
Journal:  Gastroenterology       Date:  1973-09       Impact factor: 22.682

8.  A controlled trial of azathioprine in the management of chronic ulcerative colitis.

Authors:  J L Rosenberg; A J Wall; B Levin; H J Binder; J B Kirsner
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

9.  Early surgery in the management of severe ulcerative colitis.

Authors:  J C Goligher; F T de Dombal; N G Graham; G Watkinson
Journal:  Br Med J       Date:  1967-07-22

10.  A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

Authors:  A S Dissanayake; S C Truelove
Journal:  Gut       Date:  1973-12       Impact factor: 23.059

View more
  1 in total

1.  Disease risk factors identified through shared genetic architecture and electronic medical records.

Authors:  Li Li; David J Ruau; Chirag J Patel; Susan C Weber; Rong Chen; Nicholas P Tatonetti; Joel T Dudley; Atul J Butte
Journal:  Sci Transl Med       Date:  2014-04-30       Impact factor: 17.956

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.